Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by bealerton Apr 02, 2022 8:02pm
294 Views
Post# 34570607

Good posts, Joe and Bio

Good posts, Joe and BioYou guys too are hoping for optimism and at the same time are not afraid to call this dog what it is.
The science seems to be there for at least some part of it but if the science can't get to market, what good is it revenue wise?

Ya, we all had chances to get out, and I too have made a buck or two here and there as it moved.
The problem is that we all think that 'the next time' will be the magic movement but mgmt has a way of genetically keeping that carrot alive just long enough between meals, to bamboozle most of us.

AND THEIR COMMUNICATION SKILLS!!!!!  What an awful disgrace they have made of the beautiful word 'Communication'. This is probably what hurts the most, being treated like idiot shareholders.  

Nothing communicated for weeks, months at a time. 
We could call this a reverse information war, or great mushroom feed.

Anyway, everyone have a great April!  Hopefully we'll one day get the prize we so patiently deserve.

BeAlert
<< Previous
Bullboard Posts
Next >>